Brent McKenzie

Brent McKenzie currently serves as Chief Scientific Officer at Seranova Bio, starting in October 2024. Previously, Brent held the position of VP Discovery Sciences at Sonoma Biotherapeutics from September 2021 to October 2024 and was Senior Director of Translational Immunology at Genentech from April 2014 to September 2021. Brent's expertise spans biotechnology and pharmaceutical research, specifically in small and large molecule discovery and development. Prior experience includes serving as Director of In-vivo Biology at CSL, where focus areas involved drug discovery and development, as well as leadership roles in animal models of disease. Early career accomplishments include postdoctoral fellowships at Schering-Plough Biopharma and WEHI, concentrating on autoimmune inflammation and mucosal vaccination, respectively. Brent earned a Bachelor of Science in Immunology & Pathology and a PhD in Medical Biology from the University of Melbourne.